产品展示
A8182 RSK1/2/3/4 (Phospho-Ser221/227/S218/232) Antibody
点击次数:131发布时间:2012/9/6 15:23:14
更新日期:2024/10/16 15:59:43
所 在 地:美洲
产品型号:
优质供应
详细内容
A8182 RSK1/2/3/4 (Phospho-Ser221/227/S218/232) Antibody
Reactivity | Applications | MW. | Source |
H, M | WB ELISA | 82 kDa | Rabbit |
Product Name | RSK1/2/3/4 (Phospho-Ser221/227/S218/232) Antibody |
Synonyms | S6K-alpha 1; 90 kDa ribosomal protein S6 kinase 1; p90-RSK 1; Ribosomal S6 kinase 1; RSK-1; pp90RSK1; p90S6K; MAP kinase-activated protein kinase 1a; MAPKAPK1A/ S6K-alpha 3; 90 kDa ribosomal protein S6 kinase 3; p90-RSK 3; Ribosomal S6 kinase 2; RSK-2; pp90RSK2; Insulin-stimulated protein kinase 1; ISPK-1; MAP kinase-activated protein kinase 1b; MAPKAPK1B/ S6K-alpha 2; 90 kDa ribosomal protein S6 kinase 2; p90-RSK 2; Ribosomal S6 kinase 3; RSK-3; pp90RSK3; MAP kinase-activated protein kinase 1c; MAPKAPK1C/ S6K-alpha 6; 90 kDa ribosomal protein S6 kinase 6; p90-RSK 6; Ribosomal S6 kinase 4; RSK-4; pp90RSK4 |
Immunogen | The antiserum was produced against synthesized peptide derived from human RSK1/2/3/4 around the phosphorylation site of Ser221/227/S218/232. |
Immunogen Region | Internal |
Clonality | Polyclonal |
Modification sites | H:S221/227/S218/232 M:S221/227/S218/252 |
Application dilutions | WB: 1:500~1:1000 ELISA: 1:40000 |
Specificity | RSK1/2/3/4 (Phospho-Ser221/227/S218/232) Antibody detects endogenous levels of RSK1/2/3/4 only when phosphorylated at serine221/227/S218/232. |
Purification | The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide was removed by chromatography using non-phosphopeptide corresponding to the phosphorylation. |
Physical Form | Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
Concentration | 1 mg/ml |
Storage/Stability | Store at -20℃/1 year |
NCBI Gene Symbol | RPS6KA1 | ||||||||
Database Links |
| ||||||||
Application images | Western blot analysis of extracts from HepG2 cells treated with EGF 200ng/ml 30', using RSK1/2/3/4 (Phospho-Ser221/227/S218/232) Antibody. The lane on the right is treated with the synthesized peptide. |
Related products |